Ticker: ROIV

Roivant Sciences Ltd. (NASDAQ: ROIV) - Quick inside view (Q3 FY2025, unaudited) Short take: Roivant is spending aggressively to advance its pipeline - R&D and G&A rose sharply this quarter - while sitting on a large liquid balance sheet (~$4.5B). The income statement shows a large operating loss ...

Understanding the Income Statement of Roivant Sciences Ltd. (NASDAQ: ROIV) An income statement, also known as a profit and loss statement, provides detailed insights into a company's financial performance over a specified period. It highlights revenues, expenses, and profits or losses, offering a...